Laboratory Cost Analysis of Conventional and Newer Molecular Tests for Diagnosis of Presumptive Multidrug-Resistant Tuberculosis Patients

INTRODUCTION: Tuberculosis (TB) remains a deadliest infectious disease. Lack of rapid test with low cost is one of the important challenges to eradicate the TB. The objective of the study was to analyze the laboratory costs of conventional and newer molecular tests, for diagnosis of presumptive mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Raj Narayan, Verma, Ajoy Kumar, Kaushik, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552341/
https://www.ncbi.nlm.nih.gov/pubmed/36237568
http://dx.doi.org/10.4103/jgid.jgid_309_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552341/
https://www.ncbi.nlm.nih.gov/pubmed/36237568
http://dx.doi.org/10.4103/jgid.jgid_309_21

Ejemplares similares